Get started
ABEONA THERAPEUTICABEONA THERAPEUTICABEONA THERAPEUTIC

ABEONA THERAPEUTIC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

PCJ chart


Full chart

PCJ upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪212.24 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.638 CHF
Net income (FY)
‪−57.88 M‬ CHF
Revenue (FY)
0.00 CHF
Shares float
‪43.12 M‬
Beta (1Y)
1.34

Employees


Employees (FY)
136
Change (1Y)
+52 +61.90%
Revenue / Employee (1Y)
0.00 CHF
Net income / Employee (1Y)
‪−425.61 K‬ CHF

About Abeona Therapeutics Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vishwas Seshadri
Website
abeonatherapeutics.com
Headquarters
Cleveland
Founded
1974
FIGI
BBG00LVD49M2
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PCJ news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PCJ.

Frequently Asked Questions


The current price of PCJ is 5.157 CHF — it has increased by 12.92% in the past 24 hours. Watch ABEONA THERAPEUTIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ABEONA THERAPEUTIC stocks are traded under the ticker PCJ.
PCJ stock has risen by 12.92% compared to the previous week, the month change is a 40.56% rise, over the last year ABEONA THERAPEUTIC has showed a 40.56% increase.
We've gathered analysts' opinions on ABEONA THERAPEUTIC future price: according to them, PCJ price has a max estimate of 20.67 CHF and a min estimate of 14.05 CHF. Watch PCJ chart and read a more detailed ABEONA THERAPEUTIC stock forecast: see what analysts think of ABEONA THERAPEUTIC and suggest that you do with its stocks.
PCJ reached its all-time high on Apr 28, 2025 with the price of 4.567 CHF, and its all-time low was 3.669 CHF and was reached on Nov 17, 2023. View more price dynamics on PCJ chart.
See other stocks reaching their highest and lowest prices.
PCJ stock is 11.65% volatile and has beta coefficient of 1.34. Track ABEONA THERAPEUTIC stock price on the chart and check out the list of the most volatile stocks — is ABEONA THERAPEUTIC there?
Today ABEONA THERAPEUTIC has the market capitalization of ‪231.99 M‬, it has increased by 0.83% over the last week.
Yes, you can track ABEONA THERAPEUTIC financials in yearly and quarterly reports right on TradingView.
ABEONA THERAPEUTIC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PCJ earnings for the last quarter are 0.45 CHF per share, whereas the estimation was −0.32 CHF resulting in a 243.68% surprise. The estimated earnings for the next quarter are −0.32 CHF per share. See more details about ABEONA THERAPEUTIC earnings.
ABEONA THERAPEUTIC revenue for the last quarter amounts to 0.00 CHF, despite the estimated figure of ‪90.82 K‬ CHF. In the next quarter, revenue is expected to reach 0.00 CHF.
PCJ net income for the last quarter is ‪−8.44 M‬ CHF, while the quarter before that showed ‪−25.65 M‬ CHF of net income which accounts for 67.10% change. Track more ABEONA THERAPEUTIC financial stats to get the full picture.
No, PCJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 8, 2025, the company has 136 employees. See our rating of the largest employees — is ABEONA THERAPEUTIC on this list?
Like other stocks, PCJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABEONA THERAPEUTIC stock right from TradingView charts — choose your broker and connect to your account.